Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA gives go-ahead for 5-FP clinical trials

May 24, 1996

No Comments

Gemzar approved in U.S.

May 24, 1996

No Comments

Glaxo Wellcome's new dihydrofolate reductase inhibitor 195U89

May 24, 1996

No Comments

MGI-114 receives patent protection in U.S.

May 24, 1996

No Comments

Ribonucleotide reductase inhibitor 3-AP in development at Vion

May 17, 1996

No Comments

BioChem Therapeutic will codevelop VX-710 in Canada

May 17, 1996

No Comments

SmithKline Beecham claims hemoregulatory agents

May 17, 1996

No Comments

Mitsui Toatsu claims antitumor trifluorothymidine derivatives

May 17, 1996

No Comments

Patent coverage obtained for Immune Response's cell therapy for B cell lymphoma

May 17, 1996

No Comments

Supplemental NDA filed for Novantrone in U.S.

May 17, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cancer
RSS

FDA gives go-ahead for 5-FP clinical trials

Gemzar approved in U.S.

Glaxo Wellcome's new dihydrofolate reductase inhibitor 195U89

MGI-114 receives patent protection in U.S.

Ribonucleotide reductase inhibitor 3-AP in development at Vion

BioChem Therapeutic will codevelop VX-710 in Canada

SmithKline Beecham claims hemoregulatory agents

Mitsui Toatsu claims antitumor trifluorothymidine derivatives

Patent coverage obtained for Immune Response's cell therapy for B cell lymphoma

Supplemental NDA filed for Novantrone in U.S.

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

Less microglia activity may improve APOE4’s effect in Alzheimer’s

‘Evo’ AI can design complete genomes

Cancer RSS

Cancer
RSS